Thrombophilia and complex acquired deficiencies of antithrombin, protein C, and protein S.
Humphries
J E
JE
Division of Hematology/Oncology, University of Virginia Health Sciences Center, Charlottesville, VA 22908, USA.
D000990:Antithrombin III / Q000627:therapeutic use; D020152:Antithrombin III Deficiency; D001215:Asparaginase / Q000009:adverse effects; D015415:Biomarkers; D001779:Blood Coagulation Factors / Q000378:metabolism; D001780:Blood Coagulation Tests; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D002986:Clinical Trials as Topic; D004211:Disseminated Intravascular Coagulation / Q000097:blood; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005343:Fibrinolytic Agents / Q000009:adverse effects; D006504:Hepatic Veno-Occlusive Disease / Q000097:blood / Q000150:complications; D006801:Humans; D015994:Incidence; D008107:Liver Diseases / Q000097:blood / Q000150:complications; D020151:Protein C Deficiency; D018455:Protein S Deficiency / Q000150:complications*; D012306:Risk; D013927:Thrombosis / Q000097:blood / Q000139:chemically induced / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology*
D015415:Biomarkers; D001779:Blood Coagulation Factors; D005338:Fibrin Fibrinogen Degradation Products; D005343:Fibrinolytic Agents; D000990:Antithrombin III; D001215:Asparaginase